181075-76-3

Basic information

• Product Name: (S)-3-[(S)-3-((R)-3-tert-Butoxycarbonylamino-4-methyl-pentanoylamino)-butyrylamino]-5-methyl-hexanoic acid pentafluorophenyl ester
• Synonyms: (S)-3-[(S)-3-((R)-3-tert-Butoxycarbonylamino-4-methyl-pentanoylamino)-butyrylamino]-5-methyl-hexanoic acid pentafluorophenyl ester
• CAS NO: 181075-76-3
• Molecular Weight: 609.634
• Mol File: 181075-76-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-3-[(S)-3-((R)-3-tert-Butoxycarbonylamino-4-methyl-pentanoylamino)-butyrylamino]-5-methyl-hexanoic acid pentafluorophenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-[(S)-3-((R)-3-tert-Butoxycarbonylamino-4-methyl-pentanoylamino)-butyrylamino]-5-methyl-hexanoic acid pentafluorophenyl ester(181075-76-3)
• EPA Substance Registry System: (S)-3-[(S)-3-((R)-3-tert-Butoxycarbonylamino-4-methyl-pentanoylamino)-butyrylamino]-5-methyl-hexanoic acid pentafluorophenyl ester(181075-76-3)

Safety Data

• Hazardous Substances Data: 181075-76-3(Hazardous Substances Data)

Upstream product

• 771-61-9 2,3,4,5,6-pentafluorophenol 
• 181075-71-8 Boc-(R)-β³-HVal-(S)-β³-HAla-(S)-β³-HLeu-OH 
• 13734-41-3 t-Boc-L-valine 
• 13139-15-6 N-tert-butoxycarbonyl-L-leucine 
• 75899-20-6 (C₅H₉O₂)(NHCHCOO)(CH₂C₃H₇)(CO₂C₂H₅) 
• 52716-48-0 (3S)-3-<(tert-butoxy)carbonylamino>-1-diazo-5-methylhexan-2-one 
• 98807-40-0 Boc-Val-O-COOEt 
• 86834-94-8 Boc-(S)-β³-HLeu-OMe 
• 181075-66-1 methyl (3S)-3-amino-5-methylhexanoate 
• 67865-71-8 (S)-3-(tert-butoxycarbonylamino)-1-diazo-4-methylpentan-2-one 
• 183990-64-9 (R)-3-tert-butoxycarbonylamino-4-methyl-pentanoic acid 
• 181075-63-8 Boc-(R)-β³-HVal-(S)-β³-HAla-(S)-β³-HLeu-OMe 
• 181075-67-2 Boc-(S)-β³-HAla-(S)-β³-HLeu-OMe 

Relevant articles and documents

β-Peptides: Synthesis by Arndt-Eistert homologation with concomitant peptide coupling. Structure determination by NMR and CD spectroscopy. and by X-ray crystallography. Helical secondary structure of a β-hexapeptide in solution and its stability towards p

The β-hexapeptide (H-β-HVal-β-HAla-β-HLeu)2-OH (2) was prepared from the component L-β-amino acids by conventional peptide synthesis, including fragment coupling. A cyclo-β-tri- and a cyclo-β-hexapeptide were also prepared. The β-amino acids we